Cetin, B. Et Al. 2014. Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO). JOURNAL OF CHEMOTHERAPY , vol.26, no.5 , 300-305.

Cetin, B., Benekli, M., Turker, I., Koral, L., Ulas, A., Dane, F., ... Oksuzoglu, B.(2014). Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO). JOURNAL OF CHEMOTHERAPY , vol.26, no.5, 300-305.

Cetin, Bulent Et Al. "Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)," JOURNAL OF CHEMOTHERAPY , vol.26, no.5, 300-305, 2014

Cetin, Bulent Et Al. "Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)." JOURNAL OF CHEMOTHERAPY , vol.26, no.5, pp.300-305, 2014

Cetin, B. Et Al. (2014) . "Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)." JOURNAL OF CHEMOTHERAPY , vol.26, no.5, pp.300-305.

@article{article, author={Bulent Cetin Et Al. }, title={Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)}, journal={JOURNAL OF CHEMOTHERAPY}, year=2014, pages={300-305} }